Metraipolis › archive › dc_b41ee2d676b0
5-Phenoxytryptamine — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/5-Phenoxytryptamine
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-06T17:33:02.257Z
- SHA-256 of the archived text
720548da49fee398ff2d46332fc7e60d298e76fe41fe7f75b766705b46a896c7- Stable URL of this page
https://metraipolis.com/documento/dc_b41ee2d676b0
How to cite
5-Phenoxytryptamine — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/5-Phenoxytryptamine (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_b41ee2d676b0 (Metraipolis archive dc_b41ee2d676b0, sha256 720548da49fee398ff2d46332fc7e60d298e76fe41fe7f75b766705b46a896c7)
BibTeX
@misc{dcb41ee2d676b0,
title = {5-Phenoxytryptamine — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/5-Phenoxytryptamine},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_b41ee2d676b0; sha256 720548da49fee398ff2d46332fc7e60d298e76fe41fe7f75b766705b46a896c7},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/5-Phenoxytryptamine. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
5-Phenoxytryptamine (5-PhO-T), also known as OVT2 or Otava 3736689, is a psychedelic drug of the tryptamine family related to 5-methoxytryptamine (5-MT; 5-MeO-T). It is the derivative of tryptamine and 5-methoxytryptamine in which there is a phenoxy group at the 5 position. The drug acts as a biased agonist of the serotonin 5-HT2A receptor, favoring Gαi signaling over Gαq and β-arrestin1 signaling, though not favoring Gαq signaling over β-arrestin2 signaling. Its affinity (Ki) for the serotonin 5-HT2A receptor is 57.5 nM and its activational potency at this receptor ranges from 0.28 nM to 15,800 nM and efficacy ranges from 30% to 91% depending on the downstream signaling pathway. OTV2, given via intracerebroventricular injection, produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. In addition, it produces long-term memory deficits that are dependent on serotonin 5-HT2A receptor activation in rodents. The drug was first described in the scientific literature by Elk Kossatz and colleagues in 2024. Other related compounds include OTV1, Met-I, and Nitro-I. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «5-Phenoxytryptamine» — https://en.wikipedia.org/wiki/5-Phenoxytryptamine Wikidata Q83056296: «chemical compound» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q83056296 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/5-Phenoxytryptamine?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1368833169, consultata il 2026-11-06T17:25:22.524Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 70a81f98143daa06741d8c90c94b08ff6089a6296ab6aa8506acc27594fac7a0